LA Private

December 2, 2024

Orthocell clears milestone for US launch of Remplir

Orthocell (ASX:OCC), a Perth-based regenerative medicine company, has successfully completed a pivotal US FDA 510(k) regulatory study for its nerve repair product, Remplir. The study validated Remplir as safe and effective for use in the surgical repair of peripheral nerves, meeting all required endpoints. This achievement paves the way for the submission of a marketing […]

Orthocell clears milestone for US launch of Remplir Read More »

4DMedical expands in WA

4DMedical (ASX:4DX), a Melbourne-based leader in respiratory imaging technology, has signed a contract with Perth Radiological Clinic (PRC) to deploy its XV Technology-enabled ventilation reports across 16 clinics in Perth.  XV Technology dynamically measures and visualises airflow in the lungs, enabling clinicians to detect respiratory deficiencies earlier and with greater sensitivity. By providing detailed, region-specific

4DMedical expands in WA Read More »